Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Amish Raval Added: 10 months ago
ACC 2025 - Principal results from autologous cell therapy in patients with heart failure with reduced ejection fraction (HFrEF) show favourable safety outcomes, however, the study did not meet its primary efficacy outcome using 6 minute walking rests as 3rd F-S tier.Dr Amish Raval (UW Health University Hospital Interventional Cardiology Clinic, WI, US) joins us onsite at ACC to discuss the… View more
Job title: Medical Scientist, Department of Gene and Cell Research
Research Area(s) / Expertise:

Cardio-oncology

Job title: Chief, Division of Hematology and Oncology, Perelman School of Medicine, University of Pennsylvania, US
Alison W. Loren, MD, MSCE serves as the Chief of the Division of Hematology-Oncology at the Perelman School of Medicine. Dr. Loren is the Director of Blood and Marrow Transplant in the Transplant and Cellular Therapy Program of the Abramson Cancer Center, a clinician in hematologic malignancies, and a Professor of Medicine.With an extensive portfolio of over 100 peer-reviewed publications, Dr… View more
Job title: Editor-in-Chief, Arrhythmia & Electrophysiology Review (AER)
Dr Demosthenes G Katritsis MD, PhD (London), FRCP, FESC, FACC Dr D Katritsis graduated from Athens Medical School in 1979. He trained in General Medicine at St Thomas’ Hospital, London, UK from 1981 to 1984. During the period 1985-1990 he specialized in clinical and interventional cardiology at St Thomas’ Hospital. From 1990 to 1994 he gained experience in arrhythmias and interventional… View more